The top enrichedpathways were ‘developmental processes’ (all endometriosis:P = 1.2 × 10−5; Stage B:P = 1.25 × 10−4),‘WNT signalling’ (all endometriosis:P = 1.07 × 10−4),‘gonadotropin-releasing hormone receptor’ (all endometriosis:P = 1.48 × 10−3),‘cadherin signalling’ (Stage B: P = 6.42× 10−4), ‘FGF signalling’ (Stage B:P = 2.96 × 10−3) and‘TGF-beta signalling’ (Stage B: P = 1.48× 10−3) pathways (Supplementary Material, Tables S16 and S17). The gene discussed is CDH17; the disease is endometriosis.